⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Matthew KienstraMD

Otolaryngology · Springfield, MO 65804

NPI: 1740329671

Share:𝕏fin

40

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peers99th percentile opioid prescribing

Risk indicators are statistical patterns, not allegations. Learn more

225

Total Claims

$8,515

Drug Cost

188

Beneficiaries

$45

Cost/Patient

Risk Score Breakdown 40/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Opioid rate (national percentile)+15

Score components are additive. Read full methodology

Peer Comparison vs. 8,957 Otolaryngology providers

+1361%

Opioid rate vs peers

78.2% vs 5.3% avg

-66%

Cost per patient vs peers

$45 vs $132 avg

+127%

Brand preference vs peers

7.6% vs 3.3% avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

Opioid Prescribing

78.2%

Opioid Rate

176

Opioid Claims

$1,030

Opioid Cost

Long-Acting Rate

This provider's opioid prescribing rate of 78.2% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

92% generic

Brand: 17 claims · $6,853

Generic: 208 claims · $1,662

Patient Profile

73

Avg Age

61%

Female

0.99

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About